Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by blomskompskieson Mar 14, 2013 3:47pm

111 Views

Post# 21131463

RE: News Is coming Long waited just around corner$

What Deal!? Where is this deal coming from? Dont you dare tell me something that we already know from a previous ppst or news release...This has to be New News not regurgitated*?

The Going Global innovation funding is just a 5k - 75k grant for international business deals...meetings, flights, schmoozing over clients, hotels and the like.

This is just a confirmation that the government see's this as a healthy investment for international agreements.

The PCHi - Personal Care and Homecare Ingredients Conference China 2013 ends tomorrow for those who may not know...maybe a deal was reached here???.

Bullboard Posts

Canadian artificial intelligence ETFs